Biodesix Inc

Biodesix Inc (BDSX) priced its initial public offering on Oct 29, 2020 at $18.00 per share, within its $17.00–$19.00 range, raising $72M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $472.6M. Sidley Austin advised the company and Davis Polk advised the underwriters.

Biodesix Inc is a diagnostic solutions company that uses a proprietary artificial intelligence platform to develop tests, with a primary focus on lung disease. It also provides biopharmaceutical companies with services such as diagnostic research and clinical trial testing.

Status

IPO

Ticker

BDSX

Exchange

Nasdaq Global Market

Priced

Oct 29, 2020

IPO price

$18.00

Price range

$17.00–$19.00

Raised

$72M

Market cap at IPO price

$472.6M

First filed

Oct 2, 2020

Company counsel

Sidley Austin

Underwriters' counsel

Davis Polk

Sector

Healthcare

Country / state

CO

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.